[Evaluation of the Follow-Up and State of Adolescents with Sickle-Cell Disease in Brazzaville (Congo)].
| Autor: | Ikobo LCO; Faculté des sciences de la santé, université Marien-Ngouabi de Brazzaville, Congo.; Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo., Mberi FDM; Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo., Nika ER; Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo., Mandilou SVM; Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo., Ngoulou BSA; Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo., Loufoua ABM; Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo., Mabiala-Babela JR; Faculté des sciences de la santé, université Marien-Ngouabi de Brazzaville, Congo.; Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo. |
|---|---|
| Jazyk: | francouzština |
| Zdroj: | Bulletin de la Societe de pathologie exotique (1990) [Bull Soc Pathol Exot] 2019; Vol. 112 (4), pp. 213-219. |
| DOI: | 10.3166/bspe-2019-0097 |
| Abstrakt: | The experience of the adolescent with homozygous sickle-cell disease is influenced by several factors that differentiate it from the older child entirely dependent on his parents. The objective of this study was to describe the state of health and to assess the quality of follow-up and to identify the determinants of poor monitoring of adolescent sickle-cell followed in Brazzaville for an average of 12 ± 9.6 years, starting from a cross-sectional study carried out at the Brazzaville University Hospital from March to September 2016. It is based on a questionnaire composed of elements of assessment of the state of health and the quality of the follow-up. The vaccination coverage of adolescents was low, 81.3% for DTCP, 66.5% for Typhim Vi, 50.2% for viral hepatitis B, 76.4% for pneumococcus, and 59.1% for the ROR. In the last two years prior to the survey, 99 (48.7%) adolescents had only 2 follow-up visits instead of 4 planned per year. Therapeutic compliance was good in 132 (65%). No hospitalizations were reported during this period in 23 adolescents (11.3%); in 180 cases (88.7%), however, adolescents were hospitalized one to three times apart from regular follow-up visits. Since the discovery of the disease, 177 (87.2%) adolescents had already been transfused, more than three times in 89 cases. A history of neurovascular seizures was found in 10 cases (5.2%) and priapism in 35 cases (18.2%). Paraclinical examinations were not systematic during follow-up visits. The socioeconomic level of the family and the level of education of the father had a negative impact on monitoring and adherence ( P < 0.01). On clinical examinations, stunting, undernutrition, pubertal delay, tooth decay, enuresis were found in 45.3%, 36%, 53.7%, 27.6%, 15.3%, respectively. The biological examinations carried out during the investigation showed an average inter-critical hemoglobin level between 7 and 8 g/dl, creatinine level was normal in all cases, ferritinemia was elevated in 93.6%, a negative proteinuria was found in 71.4% of the cases, and hematuria in 26.6%. Systematic abdominal ultrasound revealed vesicular lithiasis in 8 cases, hepatomegaly in 10 cases, and splenomegaly in 102 cases. Echocardiography performed in all subjects showed cardiomyopathy in 9 cases. The follow-up of the adolescent sickle-cell in Brazzaville still faces enormous difficulties. The improvement of the standard of living, the therapeutic education and the introduction of a total free of charge of the global management of sickle-cell disease would make it possible to minimize these difficulties which also would improve the future of these teenagers, adults of tomorrow. Competing Interests: The authors have no conflicts of interest to declare |
| Databáze: | MEDLINE |
| Externí odkaz: |
|